Brief reportIntracardiac echocardiography during transcatheter interventions for congenital heart disease
References (12)
- et al.
Intracardiac echocardiography in the interventional catheterization laboratorypreliminary experience with a novel, phased-array transducer
Am J Cardiol
(2002) - et al.
Intracardiac echocardiography guided device closure of atrial septal defects
J Am Coll Cardiol
(2003) - et al.
Transesophageal echocardiography during interventional catheterization in congenital heart disease
Echocardiography
(1997) - et al.
Echocardiologists' role in the deployment of the Amplatzer atrial septal occluder device in adults
J Am Soc Echocardiogr
(2001) - et al.
Brockenbrough transseptal puncture and left atrial cannulation with guidance of transesophageal and/or intracardiac echocardiography (abstr)
Circulation
(1994) - et al.
Balloon atrial septostomy in end-stage pulmonary hypertension guided by a novel intracardiac echocardiographic transducer
Cathet Cardiovasc Intervent
(2001)
Cited by (10)
Can we talk? Reflections on effective communication between imager and interventionalist in congenital heart disease
2013, Journal of the American Society of EchocardiographyCitation Excerpt :The imager should provide confirmation that the effusion diminishes with the withdrawal of fluid and report any deterioration in ventricular function to the interventionalist. Periprocedural ultrasound imaging for ASD closure is most frequently obtained by TEE, but intracardiac echocardiography (ICE)26-29 or even TTE30 may sometimes be used. The limitations of each of these modalities must be well understood by both the imager and the interventionalist.
Echocardiography-Guided Interventions
2009, Journal of the American Society of EchocardiographyCitation Excerpt :In the catheterization laboratory during these procedures, an advantage over TEE is that ICE obviates the need for general anesthesia and for additional echocardiography physician support. Compared with guidance using TEE, ICE has been shown to improve patient comfort, shorten both procedure and fluoroscopy times, and offer comparable cost with TEE-guided interventions.15-17,25,28,29 Additional uses of ICE may include guidance of transseptal catheterization, the placement of LAA occluder devices, the placement of percutaneous left ventricular assist device cannulas, the performance of PBMV, and many others.5,7,30-33
The year in echocardiography
2005, Journal of the American College of CardiologyCitation Excerpt :The use of intracardiac echocardiography to monitor transcardiac interventions continues to expand. In many institutions, intracardiac echocardiography has replaced transesophageal monitoring of device closure of atrial septal defects, patent foramen ovale, and a variety other procedures including balloon valvuloplasty, ventricular tachycardia ablation (30), and coil ablation of pulmonary A-V fistulae (31,32). Intracardiac echocardiography has several advantages over transesophageal echocardiography: it eliminates the need for general anesthesia, thus allowing greater flexibility in procedure scheduling.
Why intracardiac echocardiography?
2021, Intracardiac EchocardiographyIntracardiac echocardiography: Currently available ICE systems
2021, Intracardiac EchocardiographyPatent foramen ovale
2013, Endovascular and Hybrid Therapies for Structural Heart and Aortic Disease